Cargando…

Investigating the association between polymorphism of follicle-stimulating hormone receptor gene and ovarian response in controlled ovarian hyperstimulation

AIM: The aim of the study was to investigate the association between follicle-stimulating hormone receptor (FSHR) gene polymorphism at Position 680 and the outcomes of controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer (IVF-ET) in infertile women. MATERIALS AND METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheikhha, Mohammad Hasan, Eftekhar, Maryam, Kalantar, Seyed Mehdi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications Pvt Ltd 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205539/ https://www.ncbi.nlm.nih.gov/pubmed/22064672 http://dx.doi.org/10.4103/0974-1208.86089

Ejemplares similares

The luteinizing hormone beta-subunit exon 3 (Gly102Ser) gene mutation and ovarian responses to controlled ovarian hyperstimulation
por: Davar, Robab, et al.
Publicado: (2014)

Profile of follicle-stimulating hormone and polymorphism of follicle-stimulating hormone receptor in Madrasin cattle with ovarian hypofunction
por: Utomo, Budi, et al.
Publicado: (2020)

The Clinical Efficacy of Three Different Follicle-Stimulating Hormones for Follicle Growth and Development in Long-Protocol Controlled Ovarian Hyperstimulation Treatment
por: Zhang, Xi-Qian, et al.
Publicado: (2021)

Antral follicle count and anti-Müllerian hormone level as predictors of ovarian hyperstimulation syndrome in women with polycystic ovarian syndrome undergoing controlled ovarian stimulation
por: Izhar, Rubina, et al.
Publicado: (2021)

Association between the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) rs4073366 polymorphism and ovarian hyperstimulation syndrome during controlled ovarian hyperstimulation
por: O’Brien, Travis J, et al.
Publicado: (2013)

Continuous follicle-stimulating hormone exposure from pituitary adenoma causes periodic follicle recruitment and atresia, which mimics ovarian hyperstimulation syndrome
por: Kanaya, Mika, et al.
Publicado: (2012)

Follicle-stimulating hormone receptor gene polymorphisms of ovarian reserve markers in Romanian population
por: Tănase, Adina-Elena, et al.
Publicado: (2020)

Investigating the rate of different ovarian response in in vitro fertilization cycles based on estrogen receptor beta +1730 polymorphism: A cross-sectional study
por: Parsa, Elham, et al.
Publicado: (2020)

Follicle-stimulating hormone-secreting pituitary adenoma manifesting as recurrent ovarian cysts in a young woman – latent risk of unidentified ovarian hyperstimulation: a case report
por: Kawaguchi, Tomohiro, et al.
Publicado: (2013)

Ovarian hyperstimulation syndrome
por: Kumar, Pratap, et al.
Publicado: (2011)

Ovarian and intellectual hyperstimulation
por: Quaas, Alexander M.
Publicado: (2021)

Mutation analysis of exon1 of bone morphogenetic protein-15 gene in Iranian patients with polycystic ovarian syndrome
por: Mehdizadeh, Anahita, et al.
Publicado: (2016)

Aberrant expression of microRNAs 16 and 21 and gene targets in women with unexplained recurrent miscarriage: A case-control study
por: Karami, Noorodin, et al.
Publicado: (2018)

The Impact of Genetic Variation and Gene Expression Level of The Follicle-Stimulating Hormone Receptor on Ovarian Reserve
por: Ghezelayagh, Zeinab, et al.
Publicado: (2018)

Development of Follicle-Stimulating Hormone Receptor Binding Probes to Image Ovarian Xenografts
por: Lee, Chung-Wein, et al.
Publicado: (2015)

Variant-beta luteinizing hormone is not associated with poor ovarian response to controlled ovarian hyperstimulation
por: Hanevik, Hans I, et al.
Publicado: (2014)

Association of Follicle-Stimulating Hormone Receptor Polymorphisms with Ovarian Response in Chinese Women: A Prospective Clinical Study
por: Yan, Yuanliang, et al.
Publicado: (2013)

Autoimmunity to the Follicle-Stimulating Hormone Receptor (FSHR) and Luteinizing Hormone Receptor (LHR) in Polycystic Ovarian Syndrome
por: Schniewind, Hanna A., et al.
Publicado: (2021)

Evaluation of embryo quality after concurrent use of ovarian stimulating hormones and gamma irradiation
por: Dehghan, Tahere, et al.
Publicado: (2014)

GDF9 polymorphisms: influence on ovarian response in women undergoing controlled ovarian hyperstimulation
por: Bilibio, João Paolo, et al.
Publicado: (2020)

OR24-04 Ovarian Follicle Survival Is Determined by Follicle-Stimulating Hormone Receptor (FSHR) and Estrogen Receptor (GPER) Heteromers
por: Casarini, Livio, et al.
Publicado: (2020)

Follicle-Stimulating Hormone-Secreting Pituitary Adenoma Inducing Spontaneous Ovarian Hyperstimulation Syndrome, Treatment Using In Vitro Fertilization and Embryo Transfer: A Case Report
por: Du, Xiaofang, et al.
Publicado: (2021)

Severe Ovarian Hyperstimulation Syndrome in a Case of Nonmutated Recurrent Genuine Empty Follicle Syndrome
por: Mannur, Sumina, et al.
Publicado: (2021)

Association of follicle stimulating hormone receptor promoter with ovarian response in IVF-ET patients
por: Dan, Wang, et al.
Publicado: (2015)

Assessment of ovarian reserve: Anti-Mullerian hormone versus follicle stimulating hormone
por: Jamil, Zehra, et al.
Publicado: (2016)

Association of SNP rs.2414096 CYP19 gene with polycystic ovarian syndrome in Iranian women
por: Mehdizadeh, Anahita, et al.
Publicado: (2017)

Membrane Estrogen Receptor (GPER) and Follicle-Stimulating Hormone Receptor (FSHR) Heteromeric Complexes Promote Human Ovarian Follicle Survival
por: Casarini, Livio, et al.
Publicado: (2020)

Pharmacogenomic Biomarkers of Follicle-Stimulating Hormone Receptor Malfunction in Females with Impaired Ovarian Response—A Genetic Survey
por: Tafazoli, Alireza, et al.
Publicado: (2021)

Early onset ovarian hyperstimulation syndrome despite use of segmentation approach and ovarian hyperstimulation syndrome prophylaxis
por: Mahajan, Nalini, et al.
Publicado: (2015)

The N680S variant in the follicle-stimulating hormone receptor gene identifies hyperresponders to controlled ovarian stimulation
por: Nenonen, Hannah A., et al.
Publicado: (2019)

Ovarian cyst regression with levothyroxine in ovarian hyperstimulation syndrome associated with hypothyroidism
por: Langroudi, Roghieh Molaei, et al.
Publicado: (2013)

The investigation of cholinergic receptor muscarinic 1 activity in the rat ovary with induced ovarian hyperstimulation
por: Şanlı, Cengiz, et al.
Publicado: (2023)

The frequency of TP53 R72P and MDM2 309T>G polymorphisms in Iranian infertile men with spermatogenetic failure: A case-control study
por: Ebrahim Abadi, Zeinab, et al.
Publicado: (2018)

Progesterone-primed ovarian stimulation in polycystic ovarian syndrome: An RCT
por: Eftekhar, Maryam, et al.
Publicado: (2019)

Ovarian Hyperstimulation Syndrome, the Master of Disguise?
por: Ironside, Emily Charlotte, et al.
Publicado: (2015)

Correlation of Anti-Mullerian Hormone Level and Antral Follicle Count with Oocyte Number in A Fixed-Dose Controlled Ovarian Hyperstimulation of Patients of In Vitro Fertilization Program
por: Permadi, Wiryawan, et al.
Publicado: (2021)

The Effect of Human Growth Hormone on Endometrial Growth in Controlled Ovarian Hyperstimulation Cycles
por: Bavan, Brindha, et al.
Publicado: (2022)

Luteinizing hormone and follicle stimulating hormone synergy: A review of role in controlled ovarian hyper-stimulation
por: Raju, Gottumukkala Achyuta Rama, et al.
Publicado: (2013)

Association of GRIA1 polymorphisms with ovarian response to human menopausal gonadotropin in Iranian women
por: Golestanpour, Hossein, et al.
Publicado: (2020)

Serum Sex Hormone Binding Globulin Concentration as a Predictor of Ovarian Response During Controlled Ovarian Hyperstimulation
por: Zhai, Junyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gn2i06fjdhmi16r8e27770gnj1